Company Update – Gilead Sciences Inc. (NASDAQ:GILD) – [$$] Best Biotech Ideas for 2014
January 10, 2014 at 14:54 PM EST
[at Barrons.com] – Guggenheim Securities We outline our top ideas for 2014 in our biotechnology-coverage universe. We highlight Gilead Sciences (ticker: GILD) (rated at Buy), Celgene (CELG) (rated at Buy), Alexion Pharmaceuticals . . . → Read More: Company Update – Gilead Sciences Inc. (NASDAQ:GILD) – [$$] Best Biotech Ideas for 2014